Australia's most trusted
source of pharma news
Sunday, 25 January 2026
Posted 19 November 2025 PM
The first PBS listings for 2026 are up for grabs in 13 days and there's strong competition to make the Government's January reimbursement list.
AstraZeneca is hoping for a fast turnaround on a change to listing for Forxiga that would significantly expand its patient population in chronic kidney disease (CKD). The company won a recommendation at the PBAC September meeting and is already in Government Processes, the last stage before listing.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.